Bacillus Subtilis for Bone Health: What Research Says
Quick Summary: A review of six studies looked at how probiotics like Bacillus subtilis affect bone strength and breakdown in women after menopause. While animal research is promising, human results are mixed—some trials showed small improvements in bone density and less bone loss, but others found no big changes. This suggests Bacillus subtilis might help bone health, but more research is needed.
What The Research Found
Scientists reviewed studies to see if probiotics, including the friendly bacteria Bacillus subtilis, can boost bone mineral density (BMD)—that's basically how strong and dense your bones are—and slow down bone turnover, which is the process of old bone breaking down and new bone forming. In simple terms, the goal was to check if these gut-friendly bacteria could help prevent weak bones, especially in older women.
Key takeaways from the review:
- One study found that taking Bacillus subtilis combined with another probiotic (Lactobacillus reuteri) increased BMD in the lower back by 0.78%, compared to a 0.38% loss in the placebo group. That's a small but real win against bone thinning.
- Another trial showed Bacillus subtilis reduced a marker of bone breakdown (called sCTX) by 12.5%, meaning less of your bone material was being lost.
- However, most studies didn't see big changes in BMD at the hip or overall bone formation markers (like P1NP). Results varied a lot because of different bacteria types and doses used.
- Overall, the evidence is promising but not strong enough to say probiotics definitely improve bone health in people—unlike in animals where benefits are clearer.
This review pulls from animal and human data but focuses on women after menopause, a time when bones often weaken due to lower estrogen levels.
Study Details
This was a big-picture review (called a systematic review) of six high-quality experiments (randomized controlled trials) following strict rules from experts like Cochrane. They searched medical databases up to October 2020 and picked studies that compared probiotics to fake pills or drinks (placebos).
- Who was studied: About 455 postmenopausal women, aged 50 to 75. These are women who've gone through menopause, when bone loss often speeds up, raising risks for osteoporosis (brittle bones).
- How long: The studies lasted from 3 to 12 months—not super long, but enough to spot early changes in bones.
- What they took: Probiotic amounts and forms differed:
- One used capsules with 1 billion Bacillus subtilis plus 1 billion Lactobacillus reuteri bacteria each day.
- Another gave 500 million Bacillus subtilis bacteria daily in fermented milk.
- Placebos were plain capsules or milk without the good bacteria.
Some studies had minor issues, like not fully explaining how they randomly assigned people to groups, but overall, the research was solid.
What This Means For You
If you're a postmenopausal woman worried about bone health—like avoiding fractures from osteoporosis—Bacillus subtilis probiotics might offer a gentle boost. For example, adding it to your routine could slightly protect your spine bones or slow breakdown, especially when paired with other probiotics. Think of it as a sidekick to proven habits: eat calcium-rich foods (dairy, greens), get vitamin D from sun or supplements, and do weight-bearing exercises like walking or lifting light weights.
- Start with products listing Bacillus subtilis and a dose around 500 million to 1 billion CFUs (that's "colony-forming units," a measure of live bacteria)—but check labels for tested strains.
- It's not a magic fix; results are modest and not guaranteed. Talk to your doctor before starting, especially if you have gut issues or take bone meds.
- For men or younger folks, there's no data here—bones change differently across ages and genders.
Bottom line: Probiotics like this could be a low-risk add-on for bone support, but combine it with lifestyle basics for the best shot at strong bones.
Study Limitations
No research is perfect, and this review points out some gaps to keep in mind:
- Only six studies with small groups (40 to 121 women each), so results might not apply to everyone.
- The probiotics, doses, and how they were taken (pills vs. milk) weren't the same in every trial, making it hard to compare or combine results.
- Follow-ups were short (up to a year), and bone changes can take longer to show up fully.
- A few studies had unclear details on methods or missing data, which could skew findings.
- It only looked at postmenopausal women—no info for men, pre-menopausal women, or other groups.
Larger, longer studies with standardized probiotics are needed to confirm if Bacillus subtilis truly helps bones in real life. Until then, take these early signs as hopeful but not definitive.
Technical Analysis Details
Key Findings
This systematic review analyzed six randomized controlled trials (RCTs) to assess the effects of probiotics, including Bacillus subtilis, on bone mineral density (BMD) and bone turnover markers in postmenopausal women. While animal studies suggest probiotics enhance bone health, human evidence remains inconclusive. The review found limited but promising results: one trial demonstrated a statistically significant increase in lumbar spine BMD with a combination of Lactobacillus reuteri and B. subtilis (0.78% vs. 0.38% loss in placebo, p=0.03), and another reported reduced bone resorption markers (sCTX) with B. subtilis supplementation. However, other trials showed no significant effects on BMD or markers like P1NP (bone formation) or sCTX (bone resorption). The authors concluded that evidence is insufficient to confirm probiotic efficacy for bone health but highlighted potential for strain-specific benefits.
Study Design
The study is a systematic review of RCTs, adhering to Cochrane guidelines. Databases (MEDLINE, EMBASE, CENTRAL) were searched up to October 2020. Six placebo-controlled trials involving 455 postmenopausal women (age range: 50–75 years) were included. Intervention durations varied from 3 to 12 months. Risk of bias was assessed using the Cochrane Risk of Bias 2 Tool, with some trials rated as "some concerns" due to incomplete outcome data or deviations from intended interventions.
Dosage & Administration
Probiotic doses and formulations varied across trials:
- One study used L. reuteri 1×10⁹ CFU + B. subtilis 1×10⁹ CFU daily in capsules.
- Another administered B. subtilis 0.5×10⁹ CFU/day via fermented milk.
- Duration ranged from 3 to 12 months.
Placebo groups received inert capsules or non-probiotic milk.
Results & Efficacy
- BMD: Only one trial (n=121) showed a significant 0.78% increase in lumbar spine BMD with the L. reuteri + B. subtilis combination vs. 0.38% loss in placebo (p=0.03). Other trials found no significant changes in femoral neck or total hip BMD.
- Bone Turnover Markers:
- sCTX (resorption): Decreased by 12.5% with B. subtilis (p=0.04) in one trial but not others.
- P1NP (formation): No consistent effects observed.
- Meta-analysis was not feasible due to heterogeneity in strains, doses, and outcomes.
Limitations
- Small number of trials (n=6) and variable sample sizes (40–121 participants).
- Heterogeneity in probiotic strains, doses, and administration methods (capsules vs. food matrices).
- Short duration (3–12 months), insufficient to capture long-term skeletal effects.
- Risk of bias: Some trials had unclear randomization methods or incomplete data reporting.
- Population specificity: Findings limited to postmenopausal women; no data for men or younger individuals.
Future research should standardize strains, doses, and outcome measures while exploring mechanisms linking gut microbiota to bone metabolism.
Clinical Relevance
For postmenopausal women, probiotics containing B. subtilis may offer modest benefits for BMD and bone resorption, particularly when combined with other strains like L. reuteri. However, the mixed results and methodological limitations of included trials mean these findings should be interpreted cautiously. Clinicians might consider probiotics as adjuncts to established bone health strategies (e.g., calcium, vitamin D, weight-bearing exercise) rather than standalone interventions. Supplement users should prioritize products with clinically tested strains and CFU counts, as efficacy appears strain- and dose-dependent. Larger RCTs are needed to validate these preliminary signals.
Original Study Reference
Effects of probiotics on bone mineral density and bone turnover: A systematic review.
Source: PubMed
Published: 2023
📄 Read Full Study (PMID: 34748440)